Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,468,577
-
Share change
-
+1,980,116
-
Total reported value
-
$53,101,000
-
Put/Call ratio
-
303%
-
Price per share
-
$15.31
-
Number of holders
-
49
-
Value change
-
+$31,889,795
-
Number of buys
-
38
-
Number of sells
-
6
Institutional Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q1 2014
As of 31 Mar 2014 GALECTIN THERAPEUTICS INC - COM NEW (GALT) had 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,468,577 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Cormorant Asset Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MANGROVE PARTNERS, EAM Investors, LLC, Neuberger Berman Group LLC, DAVIDSON D A & CO, DRIEHAUS CAPITAL MANAGEMENT LLC, and MACQUARIE GROUP LTD.
This table shows 49 institutional shareholders of the security as of 31 Mar 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.